Prostate Cancer Symptoms: What to Watch For and When to Get Screened

Why is early prostate cancer often silent?

The prostate gland surrounds the urethra. Small cancers in the outer part of the prostate don't press on the urethra and cause no symptoms. By the time symptoms do appear — if they ever do — cancer may be more advanced. This is the central argument for screening in appropriate candidates: catching it before it announces itself 1Ref 1Wei JT, Barocas D, Carlsson S, et al. (2023).Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.Age-stratified PSA screening recommendations, higher risk for Black men and those with family history, BRCA2 risk, shared decision-making framework for PSA screening2Ref 2US Preventive Services Task Force (2018).Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.USPSTF recommendation for individualized PSA screening decision-making in men 55–69; benefit-harm tradeoffs; limited evidence for routine screening outside that age range.

What symptoms can prostate cancer cause — and what else causes them?

When prostate cancer does cause symptoms, they often overlap completely with benign prostatic hyperplasia (BPH), an age-related enlargement of the prostate that is not cancer. Both can cause:

• Difficulty starting urination
• A weak or interrupted urine stream
• More frequent urination, especially at night
• A feeling of incomplete bladder emptying
• Occasional blood in urine

BPH is far more common than prostate cancer and is the more likely explanation for these symptoms in most men 3Ref 3Lerner LB, McVary KT, Barry MJ, et al. (2021).Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Part I — Initial Work-up and Medical Management.BPH as the more common cause of lower urinary tract symptoms in men over 50; evaluation framework distinguishing BPH from cancer. Symptoms alone cannot distinguish which is present — that requires a clinician's evaluation.

Less common symptoms that raise more concern include blood in semen, new pelvic or lower back pain, or bone pain — particularly in the hips, back, or ribs — which can signal cancer that has spread beyond the prostate.

What is the PSA test and what do the screening guidelines say?

A PSA (prostate-specific antigen) blood test measures a protein made by the prostate. Elevated PSA can occur with prostate cancer, BPH, inflammation (prostatitis), or even recent ejaculation or vigorous physical activity — it is not a cancer-specific test. However, it is the best widely available screening signal currently available 1Ref 1Wei JT, Barocas D, Carlsson S, et al. (2023).Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.Age-stratified PSA screening recommendations, higher risk for Black men and those with family history, BRCA2 risk, shared decision-making framework for PSA screening2Ref 2US Preventive Services Task Force (2018).Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.USPSTF recommendation for individualized PSA screening decision-making in men 55–69; benefit-harm tradeoffs; limited evidence for routine screening outside that age range.

Major medical organizations generally recommend that men discuss PSA screening with their clinician at: - Age 50 for average-risk individuals - Age 45 for those at higher risk: Black men and men with a first-degree relative diagnosed with prostate cancer before age 65 - Age 40 for those at the highest risk, such as men with a BRCA2 gene variant or multiple affected relatives 1Ref 1Wei JT, Barocas D, Carlsson S, et al. (2023).Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.Age-stratified PSA screening recommendations, higher risk for Black men and those with family history, BRCA2 risk, shared decision-making framework for PSA screening2Ref 2US Preventive Services Task Force (2018).Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.USPSTF recommendation for individualized PSA screening decision-making in men 55–69; benefit-harm tradeoffs; limited evidence for routine screening outside that age range

The conversation should weigh the potential benefit of early detection against the reality that some prostate cancers found by screening are slow-growing and may never cause harm — while treatment carries real risks. This is genuinely a shared decision, not a one-size mandate.

When should I see a clinician and how urgently?

If you have urinary symptoms that are new, worsening, or persistent, a primary care visit within days to a few weeks is appropriate for non-emergency concerns. If you have visible blood in urine, significant pelvic pain, or new bone pain in a specific location, see a clinician promptly.

If you are in the age range for PSA screening and have not yet had that conversation, it is worth initiating at your next routine visit — or sooner if you have risk factors.

What to bring to the appointment: - Any prior PSA test results and dates - Description of urinary symptoms — how often, when they started, whether they have changed - Whether you've noticed blood in urine or semen - Family history: first-degree relatives with prostate cancer and at what age - Current medications, especially any that affect urination

What tests might a clinician consider?

• PSA blood test — the primary screening tool; an elevated or rising value prompts further evaluation
• Digital rectal exam (DRE) — a brief physical exam to feel the prostate for nodules or firmness; complements PSA
• Urinalysis — to look for blood, infection, or other findings explaining urinary symptoms
• Multiparametric MRI (mpMRI) — if PSA or exam raises concern, MRI helps visualize suspicious areas before biopsy
• Prostate biopsy — the definitive test for cancer, guided by ultrasound or MRI fusion when indicated
• Bone scan or CT — if advanced disease is suspected based on high PSA or bone pain